NCT04201912

Brief Summary

In Health, mucosal inflammation is prevented by TLR (Toll like receptors) that interact with Specific MAMP (microbe associated molecular pattern). Currently about 13TLRs have been identified. Among them, TLR2 and 4 recognize most organisms . Periodontal disease is mixed infection resulting due to dysbiosis . When aggravated by systemic disease the role of TLRs is detrimental for the overall state of periodontal apparatus. Type 2 diabetes is one of the systemic disease which is seen a risk factor if uncontrolled can exaggerate the titer of TLR2 and TLR4 biomarkers . Various studies have been evaluated to determine the role of TLRs in autoimmune and periodontal conditions. The purpose of this study is to determine if both TLR2 and TLR4 play equal roles in periodontal disease and in cases where periodontal disease is complicated by the presence of systemic disease. Individual role of TLR2 and TLR4 in active disease will help determine treatment strategies and will also be able to predict potential biomarker in disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 15, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 17, 2019

Completed
Last Updated

December 18, 2019

Status Verified

December 1, 2019

Enrollment Period

3 months

First QC Date

December 15, 2019

Last Update Submit

December 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Toll like receptor 2 activity

    Toll like receptor 2 activity will be measured from saliva obtained from controls, patients with periodontal disease but no diabetes and periodontal patients with diabetes

    From baseline to 5 months

Secondary Outcomes (1)

  • Toll like receptor 4 activity

    From baseline to 5 months

Study Arms (3)

control patients

PLACEBO COMPARATOR

Evaluation of Toll like receptor activity from whole saliva obtained from control patients

Diagnostic Test: saliva analysis for Toll like receptor activity

Periodontal patients without diabetes

ACTIVE COMPARATOR

Evaluation of toll like receptor activity from whole saliva obtained from periodontal patients without diabetes

Diagnostic Test: saliva analysis for Toll like receptor activity

Periodontal patients with diabetes

ACTIVE COMPARATOR

Evaluation of toll like receptor activity from whole saliva obtained from periodontal patients with diabetes

Diagnostic Test: saliva analysis for Toll like receptor activity

Interventions

Stimulated whole saliva will be obtained from patients and tested for Toll like receptor activity

Periodontal patients with diabetesPeriodontal patients without diabetescontrol patients

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \*Untreated stage 2 periodontitis patients (n-60)-Age group 21-60
  • Non Smokers
  • Diabetic patients controlled
  • Not haven taken medications in the past 3 months

You may not qualify if:

  • smoker
  • habits such as betel, tobacco chewing
  • systemically unstable, Diabetes uncontrolled patients
  • haven taken medications in the past 3 months
  • Pregnant ladies
  • Periodontal involvement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ajman University

Ajman, Dubai, 009714, United Arab Emirates

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Selection of patients by grading the patients according to criteria patients without periodontal and systemic involvement(control), patients classified as stage 2 periodontitis without systemic involvement(test group1), patients classified as stage 2 Periodontitis with systemic disease(Type 2 diabetes)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 15, 2019

First Posted

December 17, 2019

Study Start

May 1, 2019

Primary Completion

August 1, 2019

Study Completion

September 1, 2019

Last Updated

December 18, 2019

Record last verified: 2019-12

Locations